SUNHAWK BIO

Sunhawk Vision Biotech, Inc. is a drug development company based in Taipei, Taiwan, founded in 2019. It researches and develops eye drops for children's myopia and dry eye, as well as other nucleic acid-based drugs for ocular surface diseases. Its SHJ002 eye drops have completed a Phase 2 clinical trial for dry eye disease in adults and corneal erosion in patients with Sjogren's syndrome, and are in a Phase 2 trial for myopia control in young children.